Discusión 203. Tramelimumab plus durvalumab in unresectable hepatocellular carcinoma.
About this video
Advanced · Editorial review · 85% confidenceRound-12 hunt: picked; channel-level screens (sellers/exam/re-upload/devotional/vendor/events), provenance check, vendor/seller/devotional recheck and quality ranking (tier A) passed; strict per-title check + final strict pass; oEmbed verified.
A 11-minute video from Maestria de Oncologia del Igss USAC: “Discusión 203. Tramelimumab plus durvalumab in unresectable hepatocellular carcinoma.”.
Video by Maestria de Oncologia del Igss USAC, played through YouTube's embedded player.